LD270
|
CAIB |
Copper Age |
Portugal |
F |
-2564 |
-2578 |
U8a |
fasta
|
131.10
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
|
COV20126
|
BAIB |
Bronze Age |
Spain |
M |
-1746 |
-1627 |
L2a1 |
fasta
|
84.70
|
|
FASTA
Metadata
|
|
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
12705T (MT-CO1): Possible protective factor for normal tension glaucoma (Reported)
-
146C (MT-CR): Absence of Endometriosis (Reported)
-
15784C (MT-CYB): POAG - potential for association (Reported)
-
16093C (MT-CR): Cyclic Vomiting Syndrome (Reported)
-
16189C (MT-CR): Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients (Reported)
-
16192T (MT-CR): Melanoma patients (Reported)
-
16390A (MT-CR): POAG - potential for association (Reported)
|
COV20125
|
BAIB |
Bronze Age |
Spain |
U |
-1886 |
-1702 |
U2e1 |
fasta
|
103.00
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
16189C (MT-CR): Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients (Reported)
|
LU339
|
CAIB |
Copper Age |
Spain |
F |
-3007 |
-2871 |
H |
fasta
|
102.20
|
|
FASTA
Metadata
|
|
|
LU657
|
CAIB |
Copper Age |
Spain |
U |
-3500 |
-1700 |
U5b1 |
fasta
|
13.50
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
150T (MT-CR): Longevity / Cervical Carcinoma / HPV infection risk (Conflicting reports)
-
16192T (MT-CR): Melanoma patients (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
|
LD1174
|
CAIB |
Copper Age |
Portugal |
F |
-2577 |
-2456 |
U5b2 |
fasta
|
145.60
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
12634G (MT-ND5): Thyroid Cancer Cell Line (Reported)
-
13637G (MT-ND5): Possible LHON factor (Reported)
-
150T (MT-CR): Longevity / Cervical Carcinoma / HPV infection risk (Conflicting reports)
-
16270T (MT-CR): Melanoma patients (Reported)
|
LD903
|
BAIB |
Bronze Age |
Portugal |
U |
-2050 |
-1881 |
U3a1 |
fasta
|
38.30
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
150T (MT-CR): Longevity / Cervical Carcinoma / HPV infection risk (Conflicting reports)
-
16390A (MT-CR): POAG - potential for association (Reported)
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
|
Val05
|
NEIB |
Neolithic |
Spain |
U |
-3480 |
-3030 |
H1ay |
fasta
|
125.80
|
|
FASTA
Metadata
|
|
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
-
9861C (MT-CO3): AD (Reported)
|
Val3.99
|
BAIB |
Bronze Age |
Spain |
U |
-1650 |
-1430 |
H3 |
fasta
|
14.40
|
|
FASTA
Metadata
|
|
|
Val107
|
BAIB |
Bronze Age |
Spain |
U |
-1650 |
-1430 |
H1bm |
fasta
|
42.10
|
|
FASTA
Metadata
|
|
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
-
4216C (MT-ND1): LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage (Conflicting reports)
-
9055A (MT-ATP6): PD protective factor (Reported)
|
Val145
|
BAIB |
Bronze Age |
Spain |
U |
-1650 |
-1430 |
H1bm |
fasta
|
33.70
|
|
FASTA
Metadata
|
|
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
-
4216C (MT-ND1): LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage (Conflicting reports)
-
9055A (MT-ATP6): PD protective factor (Reported)
|
Val146
|
BAIB |
Bronze Age |
Spain |
U |
-1650 |
-1430 |
H1bm |
fasta
|
57.70
|
|
FASTA
Metadata
|
|
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
-
4216C (MT-ND1): LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage (Conflicting reports)
-
9055A (MT-ATP6): PD protective factor (Reported)
|
Eiros1
|
BAIB |
Bronze Age |
Spain |
U |
-1499 |
-1310 |
V |
fasta
|
72.10
|
|
FASTA
Metadata
|
|
|
Eiros2
|
NEIB |
Neolithic |
Spain |
U |
-3636 |
-3381 |
U5b3 |
fasta
|
163.80
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
150T (MT-CR): Longevity / Cervical Carcinoma / HPV infection risk (Conflicting reports)
-
16192T (MT-CR): Melanoma patients (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
-
228A (MT-CR): Low VO2max response (Reported)
|
Rebolal
|
CAIB |
Copper Age |
Spain |
U |
-3500 |
-3181 |
K2b1 |
fasta
|
72.52
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
13135A (MT-ND5): possible HCM susceptibility (Reported)
-
9055A (MT-ATP6): PD protective factor (Reported)
|
Pxevi
|
CAIB |
Copper Age |
Spain |
U |
-3354 |
-3090 |
J2a1 |
fasta
|
167.80
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
11253C (MT-ND4): LHON PD (Reported)
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
13708A (MT-ND5): LHON / Increased MS risk / higher freq in PD-ADS (Conflicting reports)
-
150T (MT-CR): Longevity / Cervical Carcinoma / HPV infection risk (Conflicting reports)
-
15257A (MT-CYB): LHON (Conflicting reports)
-
195C (MT-CR): BD-associated / melanoma pts (Reported)
-
295T (MT-CR): Low VO2max response (Reported)
-
4216C (MT-ND1): LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage (Conflicting reports)
-
489C (MT-CR): Low VO2max response (Reported)
|
Pv517
|
CAIB |
Copper Age |
Spain |
U |
-3354 |
-3090 |
K2b1 |
fasta
|
145.60
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
13135A (MT-ND5): possible HCM susceptibility (Reported)
-
146C (MT-CR): Absence of Endometriosis (Reported)
-
9055A (MT-ATP6): PD protective factor (Reported)
|